An early-stage trial has been launched of Vaxart's VXA-CoV2-1, an oral tablet COVID-19 vaccine candidate. The study will include up to 48 adult volunteers, and the tablets are stable at room temperature.
Oral COVID-19 vaccine enters early clinical testing
Sign up for AIChE SmartBrief
News for chemical engineers
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.